- Sarah Davies
Woodlands Medical Centre
Dr Davies graduated from the University of Wales College of Medicine in 2003, initially pursuing a career in medicine, especially diabetes and endocrinology. She then made the move to General Practice and continued her interest in diabetes, completing the Cardiff Postgraduate diploma in diabetes.
She has worked for five years as a GP partner in Cardiff as the diabetes lead. She is the Clinical Director for Diabetes in Primary Care for Cardiff and Vale University Health board, representing primary care in diabetes service development.
Incretin Management in Type 2 Diabetes
- Recall the components of the ‘ominous octet’ & how they contribute to T2DM development
- Identify underlying facets of clinical inertia in T2DM care
- Describe how early adoption of intensive glycaemic control leads to better outcomes in T2DM
- Recall efficacy & the mode of action of various incretin-based treatments
- Adopt an early, intensive glucose-lowering strategy in appropriate individuals
- Select appropriate incretin treatment & dosing regimens according to patient profiles
- Identify individuals likely to gain cardiovascular benefit from GLP-1RAs
- Select appropriate actions following adverse events from incretin-based treatments